Literature DB >> 18459057

Development of a GC-MS assay for the determination of fentanyl pharmacokinetics in rabbit plasma after sublingual spray delivery.

Ahmad H Malkawi1, Abeer M Al-Ghananeem, Peter A Crooks.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18459057      PMCID: PMC2751381          DOI: 10.1208/s12248-008-9031-x

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


× No keyword cloud information.
  27 in total

1.  Determination of fentanyl and related compounds by capillary gas chromatography with electron capture detection.

Authors:  J M Moore; A C Allen; D A Cooper; S M Carr
Journal:  Anal Chem       Date:  1986-07       Impact factor: 6.986

2.  Determination of fentanyl and alfentanil in plasma by high-performance liquid chromatography with ultraviolet detection.

Authors:  K Kumar; D J Morgan; D P Crankshaw
Journal:  J Chromatogr       Date:  1987-08-07

3.  Fentanyl and the metabolic response to surgery.

Authors:  G M Hall
Journal:  Br J Anaesth       Date:  1980-06       Impact factor: 9.166

4.  In vitro and in vivo evaluation of a new sublingual tablet system for rapid oromucosal absorption using fentanyl citrate as the active substance.

Authors:  Susanne Bredenberg; Margareta Duberg; Bo Lennernäs; Hans Lennernäs; Anders Pettersson; Marie Westerberg; Christer Nyström
Journal:  Eur J Pharm Sci       Date:  2003-11       Impact factor: 4.384

Review 5.  Oral mucosal drug delivery: clinical pharmacokinetics and therapeutic applications.

Authors:  Hao Zhang; Jie Zhang; James B Streisand
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 6.  Newer methods of delivery of opiates for relief of pain.

Authors:  P J Slattery; R A Boas
Journal:  Drugs       Date:  1985-12       Impact factor: 9.546

Review 7.  Clinical pharmacokinetics of fentanyl and its newer derivatives.

Authors:  L E Mather
Journal:  Clin Pharmacokinet       Date:  1983 Sep-Oct       Impact factor: 6.447

8.  Assay methods for fentanyl in serum: gas-liquid chromatography versus radioimmunoassay.

Authors:  R J Woestenborghs; D R Stanski; J C Scott; J J Heykants
Journal:  Anesthesiology       Date:  1987-07       Impact factor: 7.892

9.  Intravenous fentanyl kinetics.

Authors:  D A McClain; C C Hug
Journal:  Clin Pharmacol Ther       Date:  1980-07       Impact factor: 6.875

10.  Scopolamine sublingual spray: an alternative route of delivery for the treatment of motion sickness.

Authors:  Abeer M Al-Ghananeem; Ahmad H Malkawi; Peter A Crooks
Journal:  Drug Dev Ind Pharm       Date:  2007-05       Impact factor: 3.225

View more
  4 in total

1.  Development of controlled-release matrix tablet of risperidone: influence of Methocel®- and Ethocel®-based novel polymeric blend on in vitro drug release and bioavailability.

Authors:  Amir Badshah; Fazal Subhan; Khalid Rauf; Nadeem Irfan Bukhari; Kifayatullah Shah; Samiullah Khan; Zia Ahmed; Ihsanullah Khan
Journal:  AAPS PharmSciTech       Date:  2011-04-15       Impact factor: 3.246

2.  Controlled release matrix tablets of olanzapine: influence of polymers on the in vitro release and bioavailability.

Authors:  Amir Badshah; Fazal Subhan; Khalid Rauf
Journal:  AAPS PharmSciTech       Date:  2010-09-08       Impact factor: 3.246

3.  Pharmacokinetics and dose proportionality of fentanyl sublingual spray: a single-dose 5-way crossover study.

Authors:  Neha Parikh; Venkat Goskonda; Ashok Chavan; Larry Dillaha
Journal:  Clin Drug Investig       Date:  2013-06       Impact factor: 2.859

4.  Single-dose fentanyl sublingual spray for breakthrough cancer pain.

Authors:  Donald R Taylor
Journal:  Clin Pharmacol       Date:  2013-07-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.